Stimulation of Insulin-like Growth Factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-α is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells

Endocrinology

Volumn 145, Issue 9, 2004, Pages 4213-4221

  Sivaprasad, Usha ^a   Fleming, Jodie ^a   Verma, Poonam S ^a   Hogan, Kelly A ^a   Desury, Gwenaëlle ^a   Cohick, Wendie S ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN P85; PROTEIN SHC; SMALL INTERFERING RNA; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CATTLE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CATTLE; CELL LINE; CHROMONES; DNA; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; FLAVONOIDS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MAMMARY GLANDS, ANIMAL; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHOLINES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 4344679452     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1377     Document Type: Article

References (52)

1. Kleinberg DL, Feldman M, Ruan W 2000 IGF-I: an essential factor in terminal end bud formation and ductal morphogenesis. J Mammary Gland Biol Neoplasia 5:7-17
2. Xie W, Paterson AJ, Chin E, Nabell LM, Kudlow JE 1997 Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Mol Endocrinol 11:1766-1781
3. Sebastian J, Richards RG, Walker MP, Wiesen JF, Werb Z, Derynck R, Hom YK, Cunha GR, DiAugustine RP 1998 Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis. Cell Growth Differ 9:777-785
4. Luetteke NC, Qiu TH, Fenton SE, Troyer KL, Riedel RF, Chang A, Lee DC 1999 Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126:2739-2750
5. Sachdev D, Yee D 2001 The IGF system and breast cancer. Endocr Relat Cancer 8:197-209
6. Fischer OM, Streit S, Hart S, Ullrich A 2003 Beyond Herceptin and Gleevec. Curr Opin Chem Biol 7:490-495
7. Robinson DR, Wu YM, Lin SF 2000 The protein tyrosine kinase family of the human genome. Oncogene 19:5548-5557
8. LeRoith D, Werner H, Beitner-Johnson D, Roberts Jr CT 1995 Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143-163
9. Olayioye MA, Neve RM, Lane HA, Hynes NE 2000 The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19:3159-3167
10. Koff MD, Plaut K 1995 Expression of transforming growth factor-α-like messenger ribonucleic acid transcripts in the bovine mammary gland. J Dairy Sci 78:1903-1908
11. Plath A, Einspanier R, Peters F, Sinowatz F, Schams D 1997 Expression of transforming growth factors α and β-1 messenger RNA in the bovine mammary gland during different stages of development and lactation. J Endocrinol 155:501-511
12. Zurfluh LL, Bolten SL, Byatt JC, McGrath MF, Tou JS, Zupec ME, Krivi GG 1990 Isolation of genomic sequence encoding a biologically active bovine TGFα protein. Growth Factors 3:257-266
13. Glimm DR, Baracos VE, Kennelly JJ 1992 Northern and in situ hybridization analyses of the effects of somatotropin on bovine mammary gene expression. J Dairy Sci 75:2687-2705
14. Sheffield LG 1997 Mastitis increases growth factor messenger ribonucleic acid in bovine mammary glands. J Dairy Sci 80:2020-2024
15. Stern DF 2000 Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases. Breast Cancer Res 2:176-183
16. Petley T, Graff K, Jiang W, Yang H, Florini J 1999 Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses. Horm Metab Res 31:70-76
17. Swantek JL, Baserga R 1999 Prolonged activation of ERK2 by epidermal growth factor and other growth factors requires a functional insulin-like growth factor 1 receptor. Endocrinology 140:3163-3169
18. Ahmad T, Farnie G, Bundred NJ, Anderson NG 2004 The mitogenic action of insulin-like growth factor I in normal human mammary epithelial cells requires the epidermal growth factor receptor tyrosine kinase. J Biol Chem 279:1713-1719
19. Roudabush FL, Pierce KL, Maudsley S, Khan KD, Luttrell LM 2000 Transactivation of the EGF receptor mediates IGF-1-stimulated shc phosphorylation and ERK1/2 activation in COS-7 cells. J Biol Chem 275:22583-22590
20. Firth SM, Baxter RC 2002 Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854
21. Butt AJ, Williams AC 2001 IGFBP-3 and apoptosis - a license to kill? Apoptosis 6:199-205
22. Kim HS, Ingermann AR, Tsubaki J, Twigg SM, Walker GE, Oh Y 2004 Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells. Cancer Res 64:2229-2237
23. Grill CJ, Cohick WS 2000 Insulin-like growth factor binding protein-3 mediates IGF-I action in a bovine mammary epithelial cell line independent of an IGF interaction. J Cell Physiol 183:273-283
24. Chen J-C, Shao ZM, Sheikh MS, Hussain A, LeRoith D, Roberts Jr CT, Fontana JA 1994 Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. J Cell Physiol 158:69-78
25. Martin JL, Weenink SM, Baxter RC 2003 Insulin-like growth factor-binding protein-3 potentiates epidermal growth factor action in MCF-10A mammary epithelial cells. Involvement of p44/42 and p38 mitogen-activated protein kinases. J Biol Chem 278:2969-2976
26. Butt AJ, Martin JL, Dickson KA, McDougall F, Firth SM, Baxter RC 2004 Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: the role of altered epidermal growth factor signaling. J Clin Endocrinol Metab 89:1950-1956
27. Rocha RL, Hilsenbeck SG, Jackson JG, Lee AV, Figueroa JA, Yee D 1996 Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features. J Natl Cancer Inst 88:601-606
28. Rocha RL, Hilsenbeck SG, Jackson JG, VanDenBerg CL, Weng C, Lee AV, Yee D 1997 Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival. Clin Cancer Res 3:103-109
29. Yu H, Levesque MA, Khosravi MJ, Papanastasiou-Diamandi A, Clark GM, Diamandis EP 1996 Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer. Br J Cancer 74:1242-1247
30. Cohick WS, Wang B, Venna P, Boisclair YR 2000 Insulin-like growth factor I (IGF-I) and cyclic adenosine 3′,5′-monophosphate regulate IGF-binding protein-3 gene expression by transcriptional and posttranscriptional mechanisms in mammary epithelial cells. Endocrinology 141:4583-4591
31. Martin JL, Baxter RC 1988 Insulin-like growth factor-binding proteins (IGF-BPs) produced by human skin fibroblasts: immunological relationship to other human IGF-BPs. Endocrinology 123:1907-1915
32. Bale LK, Conover CA 1992 Regulation of insulin-like growth factor binding protein-3 messenger ribonucleic acid expression by insulin-like growth factor I. Endocrinology 131:608-614
33. Huynh HT, Robitaille G, Turner JD 1991 Establishment of bovine mammary epithelial cells (MAC-T): an in vitro model for bovine lactation. Exp Cell Res 197:191-199
34. Grill CJ, Sivaprasad U, Cohick WS 2002 Constitutive expression of IGF-binding protein-3 by mammary epithelial cells alters signaling through Akt and p70S6 kinase. J Mol Endocrinol 29:153-162
35. Gogg S, Smith U 2002 Epidermal growth factor and transforming growth factor α mimic the effects of insulin in human fat cells and augment downstream signaling in insulin resistance. J Biol Chem 277:36045-36051
36. Firth SM, Fanayan S, Benn D, Baxter RC 1998 Development of resistance to insulin-like growth factor binding protein-3 in transfected T47D breast cancer cells. Biochem Biophys Res Commun 246:325-329
37. LeRoith D 2000 Insulin-like growth factor I receptor signaling - overlapping or redundant pathways? Endocrinology 141:1287-1288
38. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW 2003 Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 284:31-53
39. Butler AA, Yakar S, Gewolb IH, Karas M, Okubo Y, LeRoith D 1998 Insulin-like growth factor-I receptor signal transducrion: at the interface between physiology and cell biology. Comp Biochem Physiol B Biochem Mol Biol 121:19-26
40. Purup S, Vestergaard M, Sejrsen K 2000 Involvement of growth factors in the regulation of pubertal mammary growth in cattle. Adv Exp Med Biol 480:27-43
41. Moorby CD, Taylor JA, Forsyth IA 1995 Transforming growth factor-α: re-ceptor binding and action on DNA synthesis in the sheep mammary gland. J Endocrinol 144:165-171
42. Lingohr MK, Dickson LM, McCuaig JF, Hugl SR, Twardzik DR, Rhodes CJ 2002 Activation of IRS-2-mediated signal transducrion by IGF-1, but not TGFα or EGF, augments pancreatic β-cell proliferation. Diabetes 51:966-976
43. Marshall M 1995 Interactions between Ras and Raf: key regulatory proteins in cellular transformation. Mol Reprod Dev 42:493-499
44. Tombes RM, Auer KL, Mikkelsen R, Valerie K, Wymann MP, Marshall CJ, McMahon M, Dent P 1998 The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic. Biochem J 330(Pt 3):1451-1460
45. Hermanto U, Zong CS, Wang LH 2000 Inhibition of mitogen-activated protein kinase kinase selectively inhibits cell proliferation in human breast cancer cells displaying enhanced insulin-like growth factor I-mediated mitogen-activated protein kinase activation. Cell Growth Differ 11:655-664
46. Jackson JG, Yoneda T, Clark GM, Yee D 2000 Elevated levels of p66 Shc are found in breast cancer cell lines and primary tumors with high metastatic potential. Clin Cancer Res 6:1135-1139
47. Lu Y, Zi X, Zhao Y, Pollak M 2004 Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells. Biochem Biophys Res Commun 313:709-715
48. Stevenson LE, Ravichandran KS, Frackelton Jr AR 1999 Shc dominant negative disrupts cell cycle progression in both G0-G1 and G2-M of ErbB2-positive breast cancer cells. Cell Growth Differ 10:61-71
49. Erondu NE, Dake BL, Moser DR, Lin M, Boes M, Bar RS 1996 Regulation of endothelial IGFBP-3 synthesis and secretion by IGF-I and TGFβ. Growth Regul 6:1-9
50. De W, Breant B, Czernichow P, Asfari M 1995 Growth hormone (GH) and prolactin (PRL) regulate IGFBP-3 gene expression in rat β-cells. Mol Cell Endocrinol 114:43-50
51. Duan C, Liimatta MB, Bottum OL 1999 Insulin-like growth factor (IGF)-I regulates IGF-binding protein-5 gene expression through the phosphatidylinositol 3-kinase, protein kinase B/Akt, and p70 S6 kinase signaling pathway. J Biol Chem 274:37147-37153
52. Burroughs KD, Oh J, Barrett JC, DiAugustine RP 2003 Phosphatidylinositol 3-kinase and mek1/2 are necessary for insulin-like growth factor-I-induced vascular endothelial growth factor synthesis in prostate epithelial cells: a role for hypoxia-inducible factor-1? Mol Cancer Res 1:312-322